Hologic, Inc. (HOLX) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Earnings Reports
-
Hologic (HOLX) Q4 2025: Interventional Revenue Climbs 32% as Breast Health Rebound Strengthens FY26 Outlook
November 04, 2025
-
Hologic (HOLX) Q3 2025: Endomag Revenue Hits $20M, Accelerating Breast Health Rebound
July 30, 2025
-
Hologic (HOLX) Q2 2025: Tariff Impact Drives $20M Quarterly Cost Headwind as China and Africa Drag on Growth
July 04, 2025